Skip to main content
. 2015 Jan 8;38(4):575–580. doi: 10.2337/dc14-1919

Table 4.

Plasma phospholipid n-3 FAs modify the association between incident type 2 diabetes and serum NEFAs, presented as HRs (95% CIs), MESA, N = 5,697

Quartiles of NEFAs Ptrend
Quartile, n 1 (n = 1,380) 2 (n = 1,461) 3 (n = 1,455) 4 (n = 1,401)
Range 0.13–0.39 0.40–0.52 0.53–0.67 0.68–2.11
Pinteraction = 0.03
Low n-3 (<75th percentile)*
 Cases, n 92 127 147 157
 Model 1, HR (95% CI) 1.0 1.41 (1.07, 1.84) 1.77 (1.35, 2.31) 2.18 (1.65, 2.88) <0.001
 Model 2, HR (95% CI) 1.0 1.30 (1.00, 1.70) 1.51 (1.15, 1.98) 1.83 (1.39, 2.43) <0.001
High n-3 (≥75th percentile)*
 Cases, n 32 39 34 29
 Model 1, HR (95% CI) 1.0 1.17 (0.72, 1.89) 1.01 (0.60, 1.70) 0.96 (0.55, 1.66) 0.85
 Model 2, HR (95% CI) 1.0 1.00 (0.61, 1.63) 0.89 (0.53, 1.51) 0.80 (0.46, 1.40) 0.83

Model 1 adjusted for age, sex, race, education, field center, smoking, and alcohol use. Model 2 adjusted for model 1 plus waist circumference and hs-CRP.

*Low n-3 FA category <75th percentile; high n-3 FA category ≥75th percentile.